EZH2 and steatosis: In the early in vivo work with EZH2 overexpression, just three weeks of overexpression led to approximately a 50% reversal in gene expression, steatosis, fibrosis, and impaired glucose tolerance, which had accumulated over an entire lifetime (~20 mo).